Patients & ProvidersHow SelfWrap WorksCompanyNewsClinical Trial
All News

VenoStent Selected as Top 20 MassChallenge Company

Oct 3, 2019

MassChallenge, a global network of zero-equity startup accelerators, announced yesterday the top 20 startups from its 2019 Boston program. These startups, among them, VenoStent, will now advance to the final judging round, where we’ll compete for cash prizes that will be awarded at the MassChallenge Awards on October 24, 2019 in Boston, Massachusetts.

One-hundred startups from six countries participated in the tenth annual MassChallenge Boston accelerator. Over the course of four months, MassChallenge provided focused curriculum, connections to a pool of over 400 experienced mentors, access to corporate partners, and connections into the rich Boston innovation ecosystem. The program’s mission is to provide founders the unique support and perspective required to grow and adapt ventures in a dynamic market.

These one-hundred startups were taken from a much larger pool of >1,000 applicants, so needless to say, we’re both humbled and honored to be considered competitive among this fabulous group of founders.

While we build out our nationwide presence, continuing to work with MassChallenge and the network that we have built there will be one of our main areas of focus and we appreciate this fabulous opportunity. Hopefully, eventually, this and we can make some truly profound changes in a few people’s lives.

SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational Device. Limited by Federal Law to Investigational Use.

COI Policy© 2024 VenoStent, Inc. All rights reserved.
2450 Holcombe Blvd, Suite J Houston, TX 77021
Follow Us